Rachel Eclov

Director & Development Project Leader

Passionate about developing personalized medicine and targeting diseases through gene therapy. With 10+ years preclinical drug development, including 5+ years leading AAV gene therapy development in rare diseases and ophthalmology. Expertise includes IND-enabling animal studies, authoring regulatory documents (US and ex-US), retinal biology, immunology, T cell biology, molecular pharmacology, pharmacokinetics/dynamics, SAR drug design, genetics and gene regulation, supported by a track record as program lead preclinical through Phase I and scientific expert on successful IND application, scientific publications, grant and fellowship funding. Exceptional public speaker with numerous scientific presentations and a passion for scientific communications. Postdoctoral training in cancer Immunotherapy at University of Chicago and Ph.D. in Pharmaceutical Sciences and Pharmacogenomics from University of California San Francisco.

Talks About
#rarediseases #developmentstrategy

Preferred Locations
#NorthAmerica